Johnson & Johnson (JNJ) Tops Q3 EPS by 7c; Boosts FY14 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Johnson & Johnson (JNJ) PT, Estimates Cut at BofA/Merrill Lynch Post Q3
October 15, 2014 7:23 AM EDTBofA/Merrill Lynch analyst Bob Hopkins lowered his price target on Johnson & Johnson (NYSE: JNJ) to $99.00 (from $106.00) while reiterated a Neutral rating following 'solid' Q3 results.
Hopkins said while solid the quarter also highlighted a number of likely EPS headwinds for... More
